CR301 Injection Foam, Part B

SECTION 2: Hazards identification

OSHA children. Dispose of contents and container in accordance with applicable local, regional and national regulations.

Signal word

DANGER

Hazard statements

Chronic As a result of previous repeated overexposure or a single large dose, certain individuals Eye Contact: This blend will cause irritation on contact. Symptoms include watering or discomfort of the eyes with marked excess redness develop isocyanine sensitization (chemical asthma) or tissue injury in the upper respiratory tract. Animal tests indicate and swelling of the conjunctiva and chemical bums of the cornea. Tertiary amines can produce a blurring of vision against a general bluish skin contact alone may also lead to allergic respiratory reaction. These effects may be permanent. Any person developing asthmatic reaction or other sensitization should be removed from further exposure. haze and the appearance of halos around bright objects (referred to as “blue haze”). Tertiary amines can also cause severe conjunctivitis. Ingestion: The tertiary amines, from this blend could cause severe irritation and possible chemical burns of the mouth, throat, esophagus and stomach Causes skin and eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Potential health effects

At room temperature, MDI vapors are minimal due to low vapor pressure. However, heating, with pain or discomfort in the mouth, throat, chest and abdomen. Symptoms include nausea, vomiting diarrhea, thirst, circulatory collapse and coma. foaming or otherwise dispersing (drumming, venting or pumping) operations may generate more vapor or aerosol concentrations of isocyanate. Excessive exposure may cause irritation of the eyes, upper respiratory tract and lungs. Inhalation: Heating, foaming or otherwise mechanically dispersing (drumming, venting or pumping) operations of this blend may generate Severe overexposure may lead to pulmonary edema. Respiratory sensitization with asthma like symptoms may occur more vapor or aerosol concentrations of its components. This blend contains tertiary amine amounts less than what is required to report as in susceptible individuals. MDI concentration below the exposure guidelines may cause allergic respiratory reactions hazardous, however the tertiary amine component is severely irritating to the upper respiratory tract and mucous membranes of the nose in individuals already sensitized. Symptoms may include coughing, dryness of throat, headache, nausea, diffi culty and throat and can result in coughing, chest discomfort and headache. breathing and feeling of tightness in the chest. Effects may be delayed. Impaired lung function (decreased ventilators capacity) has been associated with overexposure to isocyanate. Skin Contact: Prolonged contact may lead to burning associated with severe reddening, swelling and tissue destruction.

Precautionary statements

Do not handle until all safety precautions have been read and understood. Do not breathe vapors. In case of Persons With Known Respiratory or Allergy Problems Must Not Be Exposed to This Product. Carcinogenicity: MDI and polymeric MDI are not listed by the NTP, IARC or regulated by OSHA as carcinogens. Lung inadequate ventilation wear respiratory protection. Wear protective gloves and eye protection. Do not eat, drink or smoke when using this tumors have been observed in laboratory animals exposed to aerosol droplets of MDI/Polymeric MDI (6mg/m3) for product. Wash thoroughly after handling. Store locked up. Keep away from children. Dispose of contents and container in accordance with their lifetime. Tumors occurred concurrently with respiratory irritation and lung injury. Current exposure guidelines are applicable local, regional and national regulations. expected to protect against these effects.